Revelation Biosciences Inc (REVB) — Cash Flow Reinvestment Rate
Revelation Biosciences Inc (REVB) has a Cash Flow Reinvestment Rate of 2.22x as of December 2018, reinvesting $18.70 Million (capex $349.00K plus investments $-18.35 Million) from operating cash flow of $8.43 Million. Check Revelation Biosciences Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Revelation Biosciences Inc Cash Flow Reinvestment Rate (2015–2019)
Historical reinvestment intensity for Revelation Biosciences Inc across 5 annual periods. Explore Revelation Biosciences Inc (REVB) long-term investment share to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Revelation Biosciences Inc (2015–2019)
Year-by-year capital reinvestment analysis for Revelation Biosciences Inc. For live market cap and broader valuation context, see Revelation Biosciences Inc market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 8.98x | $369.13 Million | $41.09 Million | $526.00K | ▼ -1.0% |
| 2018 | 9.08x | $295.71 Million | $32.58 Million | $861.00K | ▼ -12.8% |
| 2017 | 10.41x | $252.40 Million | $24.25 Million | $804.00K | ▼ -38.8% |
| 2016 | 17.01x | $197.25 Million | $11.60 Million | $582.00K | ▲ +511.2% |
| 2015 | 2.78x | $32.27 Million | $11.60 Million | $582.00K | — |